Press release
Axillary Hyperhidrosis Clinical Trials 2024: FDA Approvals, Medication, Treatment Market, Therapies, MOA, ROA, Companies by DelveInsight
Axillary Hyperhidrosis Clinical Trials
Discover the latest drugs and treatment options in the Axillary Hyperhidrosis Pipeline. Dive into DelveInsight's comprehensive report today! @ Axillary Hyperhidrosis Pipeline Outlook- https://www.delveinsight.com/sample-request/axillary-hyperhidrosis-pipeline-insight?utm_source=openpr&utm_medium=pressrelease&utm_campaign=apr
Key Takeaways from the Axillary Hyperhidrosis Pipeline Report
• January 2024:- InMode MD Ltd.- The InMode radio frequency Pro System with the Morpheus8 Applicator is a computerized system generating radio frequency energy, based on the underlying technology of Fractional RF. The Morpheus8 Applicator and 24 pin tip is used for the treatment of primary hyperhidrosis of the axillae.
• DelveInsight's Axillary Hyperhidrosis pipeline report depicts a robust space with 3+ active players working to develop 3+ pipeline therapies for Axillary Hyperhidrosis treatment.
• The leading Axillary Hyperhidrosis Companies such as GlaxoSmithKline, Medytox, Theravida, Candesant Biomedical, and others.
• Promising Axillary Hyperhidrosis Therapies such as Sofpironium bromide, ET-01, DMT410, and others.
Stay ahead with the most recent pipeline outlook for Axillary Hyperhidrosis. Get insights into clinical trials, emerging therapies, and leading companies with DelveInsight @ Axillary Hyperhidrosis Treatment Drugs- https://www.delveinsight.com/sample-request/axillary-hyperhidrosis-pipeline-insight?utm_source=openpr&utm_medium=pressrelease&utm_campaign=apr
Axillary Hyperhidrosis Emerging Drugs
• Sofpironium bromide: Brickell Biotech Inc.
Sofpironium bromide is a new chemical entity that we are currently developing in the U.S. as a potential best-in-class, self-administered, once-daily, topical therapy for the treatment of primary axillary hyperhidrosis, or excessive underarm sweating. The drug is a retro metabolically designed anticholinergic agent which selectively binds to M3 AC receptor potentially inhibiting sweat production.
• ET-01: Eirion Therapeutics
ET-01 is a topical botulinum product being developed with the goal of avoiding the pain, bleeding and bruising that can be associated with the injection of commercially available botulinum products. ET-01 employs a nanoemulsion transdermal delivery technology essential for a large molecule such as botulinum to penetrate into the skin.The drug is currently being developed in Phase 2 stage of development for the treatment of Axillary Hyperhidrosis.
• DMT410: Dermata Therapeutics LLC pipeline
DMT410 is the second development program using DMT400 combination regimen in combination with botulinum toxin. Dermata Therapeutics have completed a proof of concept, Phase 1 clinical trial using DMT410 in combination with BOTOX® for the treatment of primary axillary hyperhidrosis. The treatment was well tolerated, and a majority of patients saw a reduction in sweat production similar to results seen from using injections of BOTOX®.
Explore groundbreaking therapies and clinical trials in the Axillary Hyperhidrosis Pipeline. Access DelveInsight's detailed report now! @ New Axillary Hyperhidrosis Drugs- https://www.delveinsight.com/sample-request/axillary-hyperhidrosis-pipeline-insight?utm_source=openpr&utm_medium=pressrelease&utm_campaign=apr
Axillary Hyperhidrosis pipeline report provides the therapeutic assessment of the pipeline drugs by the Route of Administration. Products have been categorized under various ROAs such as
• Intra-articular
• Intraocular
• Intrathecal
• Intravenous
• Ophthalmic
• Oral
• Parenteral
• Subcutaneous
• Topical
• Transdermal
Axillary Hyperhidrosis Products have been categorized under various Molecule types such as
• Oligonucleotide
• Peptide
• Small molecule
Unveil the future of Axillary Hyperhidrosis Treatment. Learn about new drugs, pipeline developments, and key companies with DelveInsight's expert analysis @ Axillary Hyperhidrosis Market Drivers and Barriers- https://www.delveinsight.com/sample-request/axillary-hyperhidrosis-pipeline-insight?utm_source=openpr&utm_medium=pressrelease&utm_campaign=apr
Scope of the Axillary Hyperhidrosis Pipeline Report
• Coverage- Global
• Axillary Hyperhidrosis Companies- GlaxoSmithKline, Medytox, Theravida, Candesant Biomedical, and others.
• Axillary Hyperhidrosis Therapies- Sofpironium bromide, ET-01, DMT410, and others.
• Axillary Hyperhidrosis Therapeutic Assessment by Product Type: Mono, Combination, Mono/Combination
• Axillary Hyperhidrosis Therapeutic Assessment by Clinical Stages: Discovery, Pre-clinical, Phase I, Phase II, Phase III
Get the latest on Axillary Hyperhidrosis Therapies and clinical trials. Download DelveInsight's in-depth pipeline report today! @ Axillary Hyperhidrosis Companies, Key Products and Unmet Needs- https://www.delveinsight.com/sample-request/axillary-hyperhidrosis-pipeline-insight?utm_source=openpr&utm_medium=pressrelease&utm_campaign=apr
Table of Content
1. Introduction
2. Executive Summary
3. Axillary Hyperhidrosis: Overview
4. Pipeline Therapeutics
5. Therapeutic Assessment
6. Axillary Hyperhidrosis- DelveInsight's Analytical Perspective
7. Late Stage Products (Phase III)
8. Sofpironium bromide: Brickell Biotech Inc
9. Drug profiles in the detailed report…..
10. Last Stage Products (Phase III)
11. Drug Name: Company Name
12. Drug profiles in the detailed report…..
13. Mid Stage Products (Phase II)
14. ET-01: Eirion Therapeutics
15. Drug profiles in the detailed report…..
16. Preclinical and Discovery Stage Products
17. Drug name: Company Name
18. Drug profiles in the detailed report…..
19. Inactive Products
20. Axillary Hyperhidrosis Key Companies
21. Axillary Hyperhidrosis Key Products
22. Axillary Hyperhidrosis - Unmet Needs
23. Axillary Hyperhidrosis - Market Drivers and Barriers
24. Axillary Hyperhidrosis - Future Perspectives and Conclusion
25. Axillary Hyperhidrosis Analyst Views
26. Axillary Hyperhidrosis Key Companies
27. Appendix
Trending Reports:
• Thyroid Eye Disease Market: https://www.delveinsight.com/report-store/thyroid-eye-disease-market
• Acute Coronary Syndrome Market: https://www.delveinsight.com/report-store/acute-coronary-syndrome-market
• Airway Stent Market Market: https://www.delveinsight.com/report-store/airway-stent-market
• Burkitt Lymphoma Market: https://www.delveinsight.com/report-store/burkitt-lymphoma-market
• Cardiac Biomarkers Testing Devices Market: https://www.delveinsight.com/report-store/cardiac-biomarkers-testing-devices-market
• Cerebral Vein Thrombosis Market: https://www.delveinsight.com/report-store/cerebral-vein-thrombosis-market
• Chemotherapy Induced Anemia Market: https://www.delveinsight.com/report-store/chemotherapy-induced-anemia-market
• Chronic Inflammatory Demyelinating Polyneuropathy Market: https://www.delveinsight.com/report-store/chronic-inflammatory-demyelinating-polyneuropathy-cidp-market
• Duchenne Muscular Dystrophy Market: https://www.delveinsight.com/blog/duchenne-muscular-dystrophy-market
• Gastric Neuroendocrine Tumours Market: https://www.delveinsight.com/report-store/gastric-neuroendocrine-tumors-market
• Hiatal Hernia Market: https://www.delveinsight.com/report-store/hiatal-hernia-market
• Image Guided Surgery Devices Market: https://www.delveinsight.com/report-store/image-guided-surgery-devices-market
• Implantable Infusion Pumps Market: https://www.delveinsight.com/report-store/implantable-infusion-pumps-market
• Pemphigus Vulgaris Market: https://www.delveinsight.com/infographics/pemphigus-vulgaris-market
• Polypoidal Choroidal Vasculopathy Market: https://www.delveinsight.com/report-store/polypoidal-choroidal-vasculopathy-market
• Postmenopausal Vaginal Atrophy Market: https://www.delveinsight.com/infographics/atrophic-vaginitis-market
• Progressive Multifocal Leukoencephalopathy Market: https://www.delveinsight.com/report-store/progressive-multifocal-leukoencephalopathy-market
• Progressive Supranuclear Palsy Market: https://www.delveinsight.com/report-store/progressive-supranuclear-palsy-market
• Arthroscopic Shavers Market: https://www.delveinsight.com/report-store/arthroscopic-shavers-market
• Chronic Rhinosinustis Market: https://www.delveinsight.com/report-store/chronic-rhinosinusitis-with-nasal-polyps-market
• Graft Versus Host Disease Market: https://www.delveinsight.com/report-store/graft-versus-host-disease-gvhd-market
• Prader-willi Syndrome Market: https://www.delveinsight.com/report-store/prader-willi-syndrome-market
• Primary Progressive Multiple Sclerosis Ppms Market: https://www.delveinsight.com/report-store/primary-progressive-multiple-sclerosis-ppms-pipeline-insight
• Turner Syndrome Market: https://www.delveinsight.com/report-store/turner-syndrome-market
• Allergic Rhinitis Market: https://www.delveinsight.com/report-store/allergic-rhinitis-market
Contact Us:
Ankit Nigam
Manager Marketing
info@delveinsight.com
+14699457679
https://www.delveinsight.com/medical-devices
Case Study: https://www.delveinsight.com/case-study/competitive-benchmarking
About DelveInsight
DelveInsight is a leading Life Science market research and business consulting company recognized for its off-the-shelf syndicated market research reports and customized solutions to firms in the healthcare sector.
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Axillary Hyperhidrosis Clinical Trials 2024: FDA Approvals, Medication, Treatment Market, Therapies, MOA, ROA, Companies by DelveInsight here
News-ID: 3728190 • Views: …
More Releases from DelveInsight Business Research
Spastic Cerebral Palsy Pipeline Overview 2024: FDA Approvals, Analysis of Clinic …
(Las Vegas, Nevada, United States) As per DelveInsight's assessment, globally, Spastic Cerebral Palsy pipeline constitutes key companies continuously working towards developing Spastic Cerebral Palsy treatment therapies, analysis of Clinical Trials, Therapies, Mechanism of Action, Route of Administration, and Developments analyzes DelveInsight.
"Spastic Cerebral Palsy Pipeline Insight, 2024" report by DelveInsight outlines comprehensive insights into the present clinical development scenario and growth prospects across the Spastic Cerebral Palsy Market.
…
Charcot Marie Tooth Disease Pipeline Analysis 2024: FDA Approvals and Emerging T …
(Las Vegas, Nevada, United States) As per DelveInsight's assessment, globally, Charcot Marie Tooth Disease pipeline constitutes 10+ key companies continuously working towards developing 15+ Charcot Marie Tooth Disease treatment therapies, analysis of Clinical Trials, Therapies, Mechanism of Action, Route of Administration, and Developments analyzes DelveInsight.
"Charcot Marie Tooth Disease Pipeline Insight, 2024" report by DelveInsight outlines comprehensive insights into the present clinical development scenario and growth prospects across…
Checkpoint Inhibitor Refractory Cancer Market Forecasted to Surge in Coming Year …
DelveInsight's "Checkpoint Inhibitor Refractory Cancer Market Insights, Epidemiology, and Market Forecast-2032″ report offers an in-depth understanding of the Checkpoint Inhibitor Refractory Cancer, historical and forecasted epidemiology as well as the Checkpoint Inhibitor Refractory Cancer market trends in the United States, EU4 (Germany, Spain, Italy, France) the United Kingdom and Japan.
To Know in detail about the Checkpoint Inhibitor Refractory Cancer market outlook, drug uptake, treatment scenario and epidemiology trends, Click…
Duchenne Muscular Dystrophy Pipeline Insights 2024: Therapies, Clinical Trials, …
(Las Vegas, Nevada, United States) As per DelveInsight's assessment, globally, Duchenne Muscular Dystrophy pipeline constitutes 75+ key companies continuously working towards developing 75+ Duchenne Muscular Dystrophy treatment therapies, analysis of Clinical Trials, Therapies, Mechanism of Action, Route of Administration, and Developments analyzes DelveInsight.
"Duchenne Muscular Dystrophy Pipeline Insight, 2024" report by DelveInsight outlines comprehensive insights into the present clinical development scenario and growth prospects across the Duchenne Muscular…
More Releases for Axillary
Massive Growth in Axillary Crutches Market, 2021-2026
(Portland, United States): Big Market Research newly added a research report on the Axillary Crutches Market which represents a study for the period from 2021 to 2026. The research study provides a near look at the market scenario and dynamics impacting its growth. This report highlights the crucial developments along with other events happening in the market which are marking on the growth and opening doors for future growth in…
Axillary Crutches Market - Size, Share, Outlook, and Opportunity
Axillary crutches are the mobility aids used by individuals suffering from walking disability, factures, paralysis, and leg injuries. Axillary crutches transfer the weight from legs to the arms/shoulders and support the movement of individuals who are unable to walk due to some disability. Axillary crutches are lightweight and they are available in various materials, which includes aluminum, stainless steel, and wooden. Axillary crutches are adjustable in size and can be…
Axillary Hyperhidrosis Pharmaceutical and Healthcare Analysis Information
Summary
Axillary hyperhidrosis also referred to as excessive underarm sweating. Excessive sweating in the affected area is caused by over activity of the nerves linked to the sweat glands. Specifically, acetylcholine, a chemical in the body that transmits nerve signals, is released from nerve endings and stimulates secretion of sweat. The condition most frequently develops in adolescence or young adulthood. Treatment includes anticholinergic drugs, surgery and antiperspirants.
GET SAMPLE REPORT @ https://www.wiseguyreports.com/sample-request/3079814-axillary-hyperhidrosis-pipeline-review-h1-2018…
Axillary Hyperhidrosis - Pipeline Research and Markets Insight, 2017
Market Research Hub (MRH) has recently publicized a new study to its vast repository, which is titled as “Axillary Hyperhidrosis - Pipeline Insight, 2017”. This report provides comprehensive insights of the ongoing therapeutic research and development across Axillary Hyperhidrosis.
Request For Sample Report@ http://www.marketresearchhub.com/enquiry.php?type=S&repid=1265422
The report provides a complete understanding of the pipeline activities covering all clinical, pre-clinical and discovery stage products. A comparative pipeline therapeutics assessment of Axillary Hyperhidrosis by development stage, therapy…
Global Axillary Crutches Market: Top Players - Invacare, Stander, Sizewise
Latest industry research report on: Global Axillary Crutches Market : Industry Size, Share, Research, Reviews, Analysis, Strategies, Demand, Growth, Segmentation, Parameters, Forecasts
Request For Sample Report @https://www.marketresearchreports.biz/sample/sample/1001065
This report studies sales (consumption) of Axillary Crutches in Global market, especially in United States, China, Europe and Japan, focuses on top players in these regions/countries, with sales, price, revenue and market share for each player in these regions, covering
Millennial Medical
Ergoactives
Cardinal Health
AMG Medical Inc/Airgo
Carex
Graham Field
Nova…
Global Axillary Crutches Market Research Report 2017
Report Hive Market Research Released a New Research Report of 102 pages on Title " Global Axillary Crutches Market Research Report 2017 "with detailed Analysis, Forecast and Strategies.
In this report, the global Axillary Crutches market is valued at USD XX million in 2016 and is expected to reach USD XX million by the end of 2022, growing at a CAGR of XX% between 2016 and 2022.
Geographically, this report is segmented…
